Skip to Content

A U of M startup has garnered seed investments to develop its faster, more accurate disease detection technology.

Vigilant Diagnostics LLC, co-founded in 2014 by U of M mechanical engineering professor John Bischof, University of Toronto researcher Warren Chan and several colleagues, is developing a technology called Thermal Contrast Amplification (TCA), which the company says can increase the accuracy of existing body fluid tests by up to eight times.

Read the full story in Twin Cities Business.